The Top Ten Scientific Problems with Biological and Chemical Evolution
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Understanding the Intelligent Design Creationist Movement: Its True Nature and Goals
UNDERSTANDING THE INTELLIGENT DESIGN CREATIONIST MOVEMENT: ITS TRUE NATURE AND GOALS A POSITION PAPER FROM THE CENTER FOR INQUIRY OFFICE OF PUBLIC POLICY AUTHOR: BARBARA FORREST, Ph.D. Reviewing Committee: Paul Kurtz, Ph.D.; Austin Dacey, Ph.D.; Stuart D. Jordan, Ph.D.; Ronald A. Lindsay, J. D., Ph.D.; John Shook, Ph.D.; Toni Van Pelt DATED: MAY 2007 ( AMENDED JULY 2007) Copyright © 2007 Center for Inquiry, Inc. Permission is granted for this material to be shared for noncommercial, educational purposes, provided that this notice appears on the reproduced materials, the full authoritative version is retained, and copies are not altered. To disseminate otherwise or to republish requires written permission from the Center for Inquiry, Inc. Table of Contents Section I. Introduction: What is at stake in the dispute over intelligent design?.................. 1 Section II. What is the intelligent design creationist movement? ........................................ 2 Section III. The historical and legal background of intelligent design creationism ................ 6 Epperson v. Arkansas (1968) ............................................................................ 6 McLean v. Arkansas (1982) .............................................................................. 6 Edwards v. Aguillard (1987) ............................................................................. 7 Section IV. The ID movement’s aims and strategy .............................................................. 9 The “Wedge Strategy” ..................................................................................... -
The Honorable Francis Collins the Honorable Anthony S. Fauci
The Honorable Francis Collins The Honorable Anthony S. Fauci Director Director National Institutes of Health National Institute of Allergy and Infectious Diseases Building 1 5601 Fishers Ln 9000 Rockville Pike Rockville, MD 20852 Bethesda, MD 20892 August 25, 2020 Dear Director Collins and Director Fauci, I want to first thank you for your tireless work to ensure that we win the fight against COVID-19. This insidious virus is not only a public health crisis, but also a crisis that is having devastating consequences on our economy. Due to the urgent nature of this pandemic, it is vitally important that we develop effective treatments and vaccines to minimize the virus’ impact and ultimately eradicate it. While I am encouraged about the progress of vaccine development for COVID-19, including the Moderna vaccine which has entered phase 3 trials, I am concerned that those living in underserved communities, especially communities of color, will not be able to easily participate in these trials. I strongly urge you to consider an additional site in Los Angeles closer to and more accessible for my demographically diverse constituents – representing populations that are desperately needed to participate in these trials. The COVID-19 crisis affects all of us, but it is the latest disease to infect and kill communities of color at higher rates than people in the rest of the population. When conducting clinical trials for treatments and vaccines for COVID-19, there needs to be an emphasis to ensure that those who are participating in the trials are racially diverse, so that there are not any disparities in terms of the effectiveness of the treatment. -
Proposed National Center for Advancing Translational Sciences Working Group
FINAL - September 21, 2011 National Institutes of Health Advisory Committee to the Director Proposed National Center for Advancing Translational Sciences Working Group SUMMARY OF FINDINGS Members: Maria Freire (chair), Julian Adams, Lee Babiss, Brook Byers, William Chin, Susan Desmond-Hellmann, David Ginsburg, Victoria Hale, Helen Hobbs, Robert Langer, Stelios Papadopoulos, Mary Pendergast, Moncef Slaoui, Marc Tessier-Lavigne, David Valle (full titles and affiliations can be found in Appendix A) Dr. Francis Collins convened a Working Group of the Advisory Committee to the NIH Director (ACD) to help identify innovative research areas and activities whereby the proposed National Center for Advancing Translational Sciences (pNCATS) can substantially contribute to catalyze, invigorate and streamline translational sciences nationally and globally (the full charge to the Working Group can be found in Appendix B). The Working Group met four times over the course of nine months. Its first meeting, on February 4, 2011, was held with members of the NIH Institute and Center Directors Working Group on pNCATS in Bethesda, Maryland. The Working Group also met via teleconference on May 24, 2011, and September 14, 2011, and held an in-person meeting in San Francisco, California, on July 15, 2011, where the group hosted two panel sessions to consult experts in project management and cross-sector partnerships (a list of participants can be found in Appendix C). The following represents the summary findings of the ACD-pNCATS Working Group over the course of these meetings. Revolutionize the Process of Translation: Goals for NCATS The creation of NCATS affords NIH a historic opportunity to catalyze, enable, and implement ground-breaking advances in translational sciences – innovations that will benefit all invested in improving human health. -
Michael Behe and the “Limits” of Evolution (Bacterial Edition). James Downard - 18 July 2014
Michael Behe and the “Limits” of Evolution (bacterial edition). James Downard - 18 July 2014 During the Kitzmiller v. Dover Intelligent Design trial in 2005, the Expert Testimony of Michael Behe (2005a) came under fire. One of the lynchpin figures in the design movement, famed for Darwin’s Black Box, his crash-and-burn performance has been amply covered in many venues, including popular coverage by Matthew Chapman (2007) and Laurie Lebo (2008). Overlooked in the heat over irreducibly complex bacterial flagella mousetraps (and whether Behe and Ken Miller would duel with lab beakers at dawn) was a minor technical issue tossed off in Behe’s deposition and afterward, which warrants examination for the insights it gives to Behe’s use of technical citation and the degree to which he investigates the strength of the ammunition he slips into his ID shotgun. Venturing into the finer points of bacterial antibiotic resistance, Behe was bowled over by the import of Barry Hall (2004a): “In Vitro Evolution Predicts that the IMP-1 Metallo-β-Lactamase Does Not Have the Potential To Evolve Increased Activity against Imipenem.” To emphasize this “limit of Darwinian evolution” Behe included a full reprint of it for the Dover court, where one could see that he had drawn a big circle around the “Not” in the title. Arbitrarily deck-stacking his point further by asserting that evolutionists think “Darwinian processes can do everything,” Behe (2005a) summarized Hall’s findings thus: This is exemplified in some recent papers from the laboratory of Professor Barry G. Hall at the University of Rochester. -
The Committee of Prominent Health Researchers and Nobel Laureates
PRESS RELEASE New York, NY, June 14, 2018 FOR IMMEDIATE RELEASE Committee of prominent health researchers and Nobel laureates renames the Prix Galien Pro Bono Humanum Award to recognize the global health leadership of Dr. Roy Vagelos was also the first recipient of the original Pro Bono Humanum Award, established in 2007 under the sponsorship of the late Foundation Honorary President and 1986 Nobel Peace Prize recipient, Pr. Elie Wiesel. That first award cited Dr. Vagelos for his unprecedented decision as CEO of a major global pharmaceutical company to donate the drug Mectizan to patients in 34 countries The Prix Galien USA Committee announced today to treat and prevent river blindness (onchocerciasis), that the Prix Galien Pro Bono Humanum Award a parasitic disease that ranks as a leading cause for individual service to improve the state of of preventable blindness in developing countries, human health will be renamed in honor of for “as much and as long as necessary.” Dr. P. Roy Vagelos, Retired Chairman and CEO, Merck & Co., Inc. Chairman of the Board, As result of this historic act of moral leadership, Regeneron Pharmaceuticals. The Roy Vagelos more than two billion treatments for 250 million Pro Bono Humanum Award for Global Health people in affected areas of the globe have been Equity will be presented at the annual Prix Galien donated by Merck & Co. over the past 30 years, USA Awards ceremony recognizing outstanding resulting in the eradication of the parasite in achievement in innovative medicines discovery on numerous countries in Africa and Latin America. Thursday, October 25, at the American Museum of Natural History in New York City. -
Plant Biology 2012…Going Communicating Plant Biology to the Mobile! General Public AAAS Fellows Class of 2011 Life Is About Choices
ASPB News THE NEWSLETTER OF THE AMERICAN SOCIETY OF PLANT BIOLOGISTS Volume 39, Number 2 March/April 2012 President’s Letter Inside This Issue Walk the Talk to Spread the Word Plant Biology 2012…Going Communicating Plant Biology to the Mobile! General Public AAAS Fellows Class of 2011 Life is about choices. plant biology is at the grocery store, where there’s TAB Articles Now Indexed on PubMed Resources (for most always a rich diversity of safe and relatively inex- of us) are limited, and pensive food. So where’s the problem we so urgently Steve Huber Teaching Tools in Plant every day we must each need to fix, one might ask. Changing this public Biology Seeks Freelance make decisions about where and how we spend perception will require innovative platforms and the Science Editors our time, efforts, and money. Likewise, federal and efforts of all ASPB members as “citizen advocates.” state governments face the continual challenge of We not only can help the public recognize there are prioritizing needs, which is especially important in many potential problems and challenges just ahead times of economic downturn when immediate and that require our action now, but also we must do “pressing” problems tend to receive heightened at- continued on page 5 tention and increased resources. One pressing problem many plant scientists wor- ry about is the sustainable production of sufficient Do you have ideas about how we (and sufficiently nutritious) food for a rapidly grow- can use social media to foster ing global population, especially in light of ongoing dialogue with the public? If so, I climate change. -
The God Hypothesis
CHAPTER 2 The God Hypothesis The religion of one age is the literary entertainment of the next. RALPH WALDO EMERSON THE GOD HYPOTHESIS 31 The God of the Old Testament is arguably the most unpleasant character in all fiction: jealous and proud of it; a petty, unjust, unforgiving control-freak; a vindictive, bloodthirsty ethnic cleanser; a misogynistic, homophobic, racist, infanticidal, genocidal, fili- cidal, pestilential, megalomaniacal, sadomasochistic, capriciously malevolent bully. Those of us schooled from infancy in his ways can become desensitized to their horror. A naif blessed with the perspective of innocence has a clearer perception. Winston Churchill's son Randolph somehow contrived to remain ignorant of scripture until Evelyn Waugh and a brother officer, in a vain attempt to keep Churchill quiet when they were posted together during the war, bet him he couldn't read the entire Bible in a fort- night: 'Unhappily it has not had the result we hoped. He has never read any of it before and is hideously excited; keeps reading quotations aloud "I say I bet you didn't know this came in the Bible ..." or merely slapping his side & chortling "God, isn't God a shit!"'16 Thomas Jefferson - better read - was of a similar opinion: 'The Christian God is a being of terrific character - cruel, vindictive, capricious and unjust.' It is unfair to attack such an easy target. The God Hypothesis should not stand or fall with its most unlovely instantiation, Yahweh, nor his insipidly opposite Christian face, 'Gentle Jesus meek and mild'. (To be fair, this milksop persona owes more to his Victorian followers than to Jesus himself. -
August 12, 2021 the Honorable Francis Collins, M.D., Ph.D. Director National Institutes of Health 9000 Rockville Pike Rockvil
August 12, 2021 The Honorable Francis Collins, M.D., Ph.D. Director National Institutes of Health 9000 Rockville Pike Rockville, MD 20892 Dear Director Collins: On May 20, 2021, we sent you a letter requesting information on the National Institutes of Health’s (NIH) 2014 funding pause on gain of function research.1 Your July 29, 2021, response failed to fully address the questions in our letter. Further, NIH’s response to us appears to be nearly identical to your response to another senator’s separate oversight request.2 Your refusal to provide detailed responses that fully address each oversight request is unacceptable. Specifically, the May 20, 2021 letter included 17 requests for documents and information on the 2014 gain of function moratorium.3 Rather than provide detailed responses to each request, NIH only offered a summary about the gain of function research moratorium and its review process for such research.4 Further, NIH claimed that no National Institute of Allergy and Infectious Diseases (NIAID) funding was approved to support gain of function research at the Wuhan lab.5 Yet, your response appeared to suggest that even approved experiments could result in a virus with a gain of function.6 Without any more detailed information, it is unclear whether this has ever occurred. NIH’s lack of response to the May 20 letter shows a complete disregard for congressional oversight and transparency. Congress and the American people have a right to know the complete truth about NIH’s role in funding potentially risky gain of function research. We expect you to specifically address all of our previous information requests and the additional requests below by no later than August 26, 2021: 1 Letter from Ron Johnson, U.S. -
Darwins-Corrosive-Idea.Pdf
This report was prepared and published by Discovery Institute’s Center for Science and Culture, a non-profit, non-partisan educational and research organization. The Center’s mission is to advance the understanding that human beings and nature are the result of intelligent design rather than a blind and undirected process. We seek long-term scientific and cultural change through cutting-edge scientific research and scholarship; education and training of young leaders; communication to the general public; and advocacy of academic freedom and free speech for scientists, teachers, and students. For more information about the Center, visit www.discovery.org/id. FOR FREE RESOURCES ABOUT SCIENCE AND FAITH, VISIT WWW.SCIENCEANDGOD.ORG/RESOURCES. PUBLISHED NOVEMBER, 2016. © 2016 BY DISCOVERY INSTITUTE. DARWIN’S CORROSIVE IDEA The Impact of Evolution on Attitudes about Faith, Ethics, and Human Uniqueness John G. West, PhD* EXECUTIVE SUMMARY In his influential book Darwin’s Dangerous Idea, have asked about the impact of science on a person’s philosopher Daniel Dennett praised Darwinian religious faith typically have not explored the evolution for being a “universal acid” that dissolves impact of specific scientific ideas such as Darwinian traditional religious and moral beliefs.1 Evolution- evolution.5 ary biologist Richard Dawkins has similarly praised In order to gain insights into the impact of Darwin for making “it possible to be an intellect- specific scientific ideas on popular beliefs about ually fulfilled atheist.”2 Although numerous studies God and ethics, Discovery Institute conducted a have documented the influence of Darwinian nationwide survey of a representative sample of theory and other scientific ideas on the views of 3,664 American adults. -
Signature of Controversy
I n “In this volume Granville Sewell provides “As the debate over intelligent design grows T delightful and wide-ranging commentary on increasingly heated... it is refreshing to find a HE the origins debate and intelligent design... discussion of the topic that is calm, thoughtful, Sewell provides much needed clarity on topics and far-ranging, with no sense of having to B e ignature f that are too often misunderstood. His discussion advance an agenda or decimate the opposition. G I S o of the commonly confused problem of entropy In this regard, Granville Sewell’s In the NNI is a must read.” Beginning succeeds brilliantly.” Cornelius G. Hunter, Ph.D. William A. Dembski, Ph.D. N author of The Design Inference author of Science’s Blind Spot G ontroversy A N c In this wide-ranging collection of essays on origins, mathematician Granville Sewell looks at the D big bang, the fine-tuning of the laws of physics, and the evolution of life. He concludes that while O there is much in the history of life that seems to suggest natural causes, there is nothing to support THER Responses to critics of signature in the cEll Charles Darwin’s idea that natural selection of random variations can explain major evolutionary E S advances (“easily the dumbest idea ever taken seriously by science,” he calls it). Sewell explains S A Y why evolution is a fundamentally different and much more difficult problem than others solved s ON by science, and why increasing numbers of scientists are now recognizing what has long been I obvious to the layman, that there is no explanation possible without design. -
CARL ZIMMER Author & Journalist
CARL ZIMMER Author & journalist carlzimmer.com @carlzimmer BIOGRAPHY The New York Times Book Review calls Carl Zimmer "as fine a science essayist as we have." He is the author of thirteen acclaimed books and a columnist for the New York Times. Zimmer first be- gan writing about science at Discover, where he served for five years as a senior editor, and has gone on to write hundreds of features for magazines including The Atlantic, The New York Times Magazine, Time, National Geographic, and Scientific American. He has also served as a scientific editor for television documentaries, consulted on museum exhibits, and contributed his writing to major science web sites. Zimmer has earned numerous honors for his work. In 2007 he won the National Academies Communication Award, and he has won the American Association for the Advancement of Sci- ences Science Journalism Award three times. In 2015, Zimmer won the Distinguished Service Award from the National Association of Biology Teachers, and in 2016, he won the Stephen Jay Gould Prize, awarded by the Society for the Study of Evolution. In 2018, Zimmer’s book She Has Her Mother’s Laugh was named by Publisher’s Weekly one of the ten best books of the year. The Guardian named it the best science book of 2018 and The New York Times Book Review chose it as a Notable Book of the Year. It was short-listed for the Baillie-Gifford Prize for Nonfiction and a fi- nalist for the PEN/E.O. Wilson Literary Science Writing Prize. His articles have been antholo- gized in both The Best American Science and Nature Writing series and The Best American Science Writing series. -
Discovering ID.Indd
DISCOVERING INTELLIGENT DESIGN A JOURNEY INTO THE SCIENTIFIC EVIDENCE Gary Kemper Hallie Kemper Casey Luskin DISCOVERY INSTITUTE PRESS, SEATTLE, WA Description The Discovering Intelligent Design textbook is part of a comprehensive curriculum that presents both the biological and cosmological evidence in support of the scientific theory of intelligent design. Developed for middle-school-age students to adults, the curriculum also includes a workbook with learning activities and a DVD with video clips keyed to the content of the textbook. Produced by Discovery Institute in conjunction with Illustra Media, the curriculum is intended for use by homeschools and private schools. The curriculum is divided into six modules that explore topics such as the origin and development of the universe, the origin of biological complexity, the fossil record’s evidence (or lack thereof) for universal common descent, and the broader cultural debate over intelligent design. More information can be obtained by visiting the curriculum’s website, http://discoveringid.org. Copyright Notice Copyright © 2013 by Gary Kemper, Hallie Kemper, and Casey Luskin. All Rights Reserved. Library Cataloging Data Discovering Intelligent Design: A Journey into the Scientific Evidence by Gary Kemper, Hallie Kemper, and Casey Luskin 286 pages, 8.5 x 11x 0.6 inches or 280 x 216 x 15 mm, 1.5 lbs or 680 g. Library of Congress Control Number: 2013934288 BISAC: SCI015000 SCIENCE/Cosmology BISAC: SCI027000 SCIENCE/Life Sciences/Evolution BISAC: SCI034000 SCIENCE/History BISAC: SCI075000 SCIENCE/Philosophy & Social Aspects ISBN-13: 978-1-936599-08-0 ISBN-10: 1936599082 Publisher Information Discovery Institute Press, 208 Columbia Street, Seattle, WA 98104 http://www.discoveryinstitutepress.com Published in the United States of America on acid-free paper.